Trial Profile
A Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Effect on Unassisted Erectile Function of the Early Use of Tadalafil 5 mg Once a Day and Tadalafil 20 mg On Demand Treatment for 9 Months in Subjects Undergoing Bilateral Nerve-Sparing Radical Prostatectomy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Dec 2021
Price :
$35
*
At a glance
- Drugs Tadalafil (Primary)
- Indications Erectile dysfunction
- Focus Therapeutic Use
- Acronyms LVIK; REACTT
- Sponsors Eli Lilly and Company
- 18 Dec 2021 This trial has been completed in Portugal, according to European Clinical Trials Database record.
- 16 Dec 2021 This trial has been completed in France, according to European Clinical Trials Database record.
- 13 Apr 2014 Results presented at the 29th Congress of the European Association of Urology.